E-Mail
The American College of Cardiology (ACC), in collaboration with Novo Nordisk A/S, today announced a new global program to support improvements in multidisciplinary care for people with Type 2 diabetes. Through the global UNITE (Multidisciplinary Teams In Cardiometabolic Care) program, clinicians across multiple specialties will receive the education and tools needed for an integrated approach to Type 2 diabetes and cardiovascular disease care. Despite advances in care, people with Type 2 diabetes continue to face a higher risk of death and disability from cardiovascular disease, said Athena Poppas, MD, FACC, ACC president. New strategies for managing this complex disease are needed. Through UNITE, we re meeting that need by providing guidance and tools that can be easily integrated into day-to-day clinical practice to optimize cardiovascular risk through treatment pathways and collaborative management of comorbidities.